HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Links / Real World Evidence (RWE) Solutions Market by Component, Application, End User – Global Forecast to 2024

Real World Evidence (RWE) Solutions Market by Component, Application, End User – Global Forecast to 2024

The real-world evidence (RWE) solutions market is expected to grow at a CAGR of 15% from 2019 to reach $1.64 billion by 2024.

The researchers believe that explosive growth will be driven by a variety of factors. These include rising geriatric population and burden of chronic diseases, the shift towards value-based care, and growing focus on personalized health care.

In addition, factors such as increasing R&D expenditure in life sciences industry, delays in drug development along with a subsequent increase in development costs and the expanding use of RWE for regulatory decision making are also supporting the growth of the market.

However, uneven quality of real-world data sources and lack of standards are expected to hinder the growth of real-world evidence (RWE) solutions market to some extent.

The significant potential in emerging markets, the rising focus on end-to-end RWE services, and emerging roles of wearable devices and AI in RWE represent high-growth opportunities for players operating in real-world evidence solutions market.

Real-world data sets are widely adopted by end-users for RWE for various applications such as drug development & approvals, market access & reimbursement/coverage decisions, clinical decision-making, and medical device development & approvals, among others.

The report states that drug development & approvals currently accounts for the largest share of the total market owing to increasing need for additional insights on epidemiology, compliance, adherence, and costs in a realistic environment; increasing demand for RWD and RWE to accelerate drug discovery and development; growing investment by biopharmaceutical companies in R&D; and growing inclination of regulatory bodies towards RWE.

Pharmaceutical, biotechnology & medical device companies were the leading adopters of real-world evidence solutions in 2018 and are also expected to register the fastest growth during the forecast period. This is attributed to the increasing importance of RWE studies in drug development and approvals, growing focus to avoid costly drug recalls, increasing need to assess drug performance in real-world settings, and growing emphasis on drug safety and post-market surveillance.

An in-depth analysis of geographic scenario of the industry provides detailed qualitative and quantitative insights about the four major geographies (North America, Europe, Asia-Pacific, and Rest of the World) along with the coverage of major countries in each region.

North America commanded the largest share of the real-world evidence solutions market in 2018, followed by Europe and Asia-Pacific. The largest share and fastest growth of this region is mainly attributed to the significant availability of real-world data sets, growing focus on value-based care, rising R&D expenditure by the biopharma companies, greater emphasis on early drug/device development and approvals, presence of major RWE players in the region, stringent regulations for drug approvals, and supporting government policies (implementation of 21st Century Cures Act (December 2016) and FDA’s new 2019 strategic Framework for RWE (December 2018) in the U.S).

Some of the major players operating in the RWE solutions market are Anthem, Clinigen Group, Cognizant, IBM Corporation, ICON, IQVIA, Optum, OracleCorporation, PAREXEL International Corporation, PerkinElmer, Pharmaceutical Product Development, SAS Institute, and Syneos Health, among several others.

ResearchandMarkets.com, March 2019



You might also be interested in:

  • Government, Big Pharma, and The People: A Century of Dis-Ease 12/03/2020
  • Syapse and FDA Leverage Real-World Data to Study Impact of… 10/05/2020
  • Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
  • How HEOR Professionals Can Be Force Multipliers in the Fight… 10/06/2020
  • Matthew McHugh Appointed Director for Health Outcomes and… 02/10/2021
  • Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
  • Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Whitepaper: The Role of Centralized Care Management in Value-based Care
  • 2017 In-Depth Outlook on Oncology Report
  • Value-Based Healthcare: Making it Happen
  • Value-Based Contracting for Biopharmaceuticals Moves Forward
  • ICER Releases White Paper on Gene Therapy

Syndicated Reports

  • HTA in Europe: Key Success Factors for Positive HTA Recommendations
  • Paying for Digital Health: Payer Insights
  • Benchmarking Pharma’s MSL Capabilities
  • Biosimilars: US Payer Perspectives
  • KAM Metrics: Driving Efficiency, Measuring Success
HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute